Disclosed herein are compositions and methods for treatment of spinal muscular atrophy (SMA). In certain embodiments, compounds are provided that increase full-length survival of motor neuron (SMN) protein production by an SMN2 gene.
US Patent 09895358 Combination therapies for treatment of spinal muscular atrophyUS Patent 9895358 Combination therapies for treatment of spinal muscular atrophy